{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3044, 
        3050
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4218, 
        4224
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2995, 
        3004
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3051, 
        3060
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3813, 
        3822
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3885, 
        3894
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4142, 
        4151
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4188, 
        4197
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2750, 
        2773
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2868, 
        2884
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8160, 
        8180
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8182, 
        8190
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2905, 
        2932
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2934, 
        2944
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        658, 
        662
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        918, 
        922
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2955, 
        2959
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3235, 
        3239
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3957, 
        3961
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4110, 
        4114
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8100, 
        8104
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        2173, 
        2192
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4064, 
        4083
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8128, 
        8148
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        548, 
        577
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        579, 
        596
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8036, 
        8062
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8064, 
        8082
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3260, 
        3283
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2978, 
        2986
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3061, 
        3068
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3804, 
        3812
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3876, 
        3884
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4133, 
        4141
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4171, 
        4179
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3039, 
        3040
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4619, 
        4626
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        663, 
        669
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        923, 
        929
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2947, 
        2953
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2987, 
        2994
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3902, 
        3908
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3949, 
        3955
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4180, 
        4187
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8092, 
        8098
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        598, 
        600
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        906, 
        908
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        2161, 
        2163
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2944, 
        2946
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3200, 
        3202
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3946, 
        3948
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8084, 
        8091
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        8120, 
        8127
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6433, 
        6465
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6467, 
        6476
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\n\n\nPath report.gross observation\n\nGross description: A. Intraoperative Consultation:  Received: fresh  Specimen: left breast wide excision  Pathologic Evaluation: immediate gross evaluation margins  Diagnosis: IOC: mass; margins are grossly negative  Communicated to: Dr. Byrnett at 10:35 AM on 08/01/2017, Tara Rubinas M.D.  Tissue submitted: not applicable \n A. Labeled: left breast wide excision Time in fixative: 10:35 AM Cold Ischemic Time: 24 minutes (according to requisition at 10:11 AM) Total formalin fixation time 8.5 hours Type of specimen: excision Location of specimen: left Size of specimen: 7.2 (medial-lateral) by 5.0 (superior-inferior) by 2.9 (anterior-posterior) centimeter Skin: not present \n Direction of compression: anterior - posterior Needle localization: no \n Orientation of specimen: cranial and medial metallic markers Superior = blue Inferior = green Medial = yellow Lateral = orange Posterior = black Anterior/Superficial = red \n Biopsy site: present Presence/absence of discrete mass: present Number of discrete masses: 1 \n Size of mass: 1.0 x 0.8 x 0.6 cm \n Description of mass: firm tan surrounding lobulated fibrosis Distance between masses/clips: not applicable Distance of mass/ biopsy site/clip to surgical margins: anterior-1.2 centimeters, inferior-1.1 cm, superior-1.6 cm, medial-1.0 cm, posterior-1.0 cm and lateral-2.6 cm \n Description of remainder of tissue: yellow lobulated fibrofatty with some more firm fibrous areas \n Block summary: 1-6-entire mass from lateral towards medial sequentially (biopsy site clip in 4) 7-perpendicular lateral 8-perpendicular superior \n \n B. Labeled: Sentinel lymph node #1 and #2 Tissue fragments: 3 \n Size: 1.5 x 1.0 x 0.6; 1.1 x 0.6 x 0.2 cm; 1.0 x 0.6 x 0.2 cm \n Description: first is a blue tinged lymph node candidate which is bisected, second 2 fragments have firm areas suggestive of lymph node \n Block summary 1-bisected blue tinged lymph node 2-two remaining fragments intact \n \n /MSO\n\n\nPayment procedure\n\nCPT                            .883071, 883072, 883291, 883601, 883602, 883603\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C50.812\n\n\nPath report.relevant Hx\n\nPre-operative diagnosis: Left breast cancer\nPost-operative diagnosis: Same as pre-op \n \n \n .\nClinical history: None provided ..\n\n\nPath report.final diagnosis\n\nDiagnosis:A. BREAST, LEFT; WIDE EXCISION: - INVASIVE MAMMARY CARCINOMA OF NO SPECIAL TYPE, 0.6 CM, GRADE 3. - DUCTAL CARCINOMA IN SITU (DCIS), HIGH GRADE, AT LEAST 3-4 CM IN LINEAR EXTENT. - BIOPSY SITE CHANGES AND MARKER CLIP PRESENT. - ALL MARGINS APPEAR CLEAR. \n B. SENTINEL LYMPH NODES #1 AND #2, LEFT AXILLA; EXCISION: - NEGATIVE FOR MALIGNANCY, TWO NODES (0/2). \n Comment: ER, PR, and HER2 assessment by immunohistochemistry is being repeated and the results will be reported in an addendum. HER2 FISH will be performed for 2+ IHC. \n Extent of DCIS is estimated based on the distance of DCIS from the inferior margin (0.2 cm), and superior margin (0.5 cm), and the inferior-superior specimen measurement of 5 cm in a compressed specimen (anterior-posterior compression). DCIS is less than 0.1 cm from the medial margin. The broad span of DCIS accompanying a small invasive carcinoma represents an extensive intraductal component (EIC). INVASIVE CARCINOMA OF THE BREAST: Complete Excision Specimens InvolvedA: Breast, left, wide excision \n SPECIMEN Procedure:   Excision with image-guided localization Lymph Node Sampling:   Sentinel lymph node(s) Specimen Laterality:   Left TUMOR Presence of Invasive Carcinoma:  Histologic Type: Invasive mammary carcinoma of no special type (ductal, not otherwise specified) Histologic Grade:  Glandular (acinar) / tubular differentiation: Score 3 (< 10% of tumor area forming glandular / tubular structures) Nuclear pleomorphism: Score 3 (vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms) Mitotic rate: Score 3 (>=8 mitoses per mm2) Overall grade: Grade 3 (scores of 8 or 9) Ductal Carcinoma In Situ (DCIS):  DCIS is present Positive for EIC Tumor Size / Focality:  Tumor size: size of largest invasive carcinoma: Greatest dimension of largest focus of invasion > 1 mm: 6mm Tumor focality:   Single focus of invasive carcinoma Tumor Extent Macroscopic and Microscopic Extent of Tumor Skin:   Specimen does not contain skin Skeletal muscle:  Specimen does not contain skeletal muscle Accessory Tumor Findings Lymph-Vascular Invasion: Not identified Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy: No known presurgical therapy MARGINS Invasive Carcinoma: Margins negative for invasive carcinoma Distance from closest margin: 8mm Closest Negative Margin(s):  Posterior Ductal Carcinoma In Situ (DCIS):  Margins negative for DCIS (DCIS present in specimen) Distance of DCIS from closest margin:  Distance is < 1 mm Closest Negative Margin(s):  Medial LYMPH NODES Regional Lymph Nodes:  Number of Sentinel Nodes Examined: Specify number 2 Number of lymph node(s) examined: Number 2 Lymph node involvement: All lymph nodes are negative STAGE (pTNM) TNM Descriptors:  Not applicable Primary Tumor (Invasive Carcinoma) (pT):   pT1b: tumor > 5 mm but <= 10 mm in greatest dimension Regional lymph nodes (pN) (choose a category based on lymph nodes received with the specimen; immunohistochemistry and / or molecular studies are not required) Modifier: (sn): only sentinel node(s) evaluated. if 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used. Category (pN): pN0: no regional lymph node metastasis identified histologically Distant Metastasis (pM): Not applicable - pM cannot be determined from the submitted specimen(s) \n \n \n MSO/08/07/2017 **********************************************************************\n\n\nPath report.supplemental reports\n\nAddendum: \n Breast Biomarker Reporting Template Specimens InvolvedA: Breast, left, wide excision \n Breast, Biomarker Reporting Template BREAST BIOMARKER TESTS Test(s) Performed: Estrogen Receptor (ER) Results: POSITIVE  Range: 1-10% Test Type:   FDA cleared (Ventana) Primary Antibody:  SP1 Progesterone Receptor (PgR) Results: NEGATIVE Internal controls present and PgR positive (as expected) Test Type:   FDA cleared (Ventana) Primary Antibody:  1E2 HER2 (ERBB2) by Immunohistochemistry (IHC) Results: Negative (Score 1+) Percentage of Cells with Uniform Intense Complete Membrane Staining: 0% Test Type:   Food and Drug Administration (FDA) cleared (DAKO) Primary Antibody:  HercepTest METHODS Cold Ischemia and Fixation Times: Meet requirements specified in the latest version of ASCO / CAP guidelines Cold ischemia time (mins)::  24 Time of fixation (hours)::  8.5 Testing performed on block number(s) (specify):: A2 Fixative: Formalin Image Analysis:   Not performed Comment(s):: IHC slides were prepared by LabCorp Center for Molecular Biology and Pathology, RTP, NC, and interpreted by Dr. Olney. All controls stained appropriately. \n \n \n \n \n Addendum #1 performed by Electronically signed 8/7/2017 3:35:57PM \n \n \n Technical component performed at LabCorp, 1447 York Court, Burlington, NC 27215 Lab: 800-762-4344 Dir: William F. Hancock, MD \n Professional component performed at LabCorp, Alamance Regional Medical Center, 1240 Huffman Mill Rd, Burlington, NC 27215 Lab: 336-538-7833 Dir: Tara C. Rubinas, MD \n MSO/08/07/2017 Addendum Electronically Signed by\n\n\nPath report.site of origin\n\nMaterial submitted: PART A: Breast, left, wide excision PART B: Lymph node, sentinel, 1 and 2\n\n\nPath report.comments\n\nComment:CASE: PATIENT: Final Diagnosis performed by  Electronically signed 8/3/2017 7:28:47PM \n \n The electronic signature indicates that the named Attending Pathologist has evaluated the specimen \n Technical component performed at LabCorp, 1447 York Court, Burlington, NC 27215 Lab: 800-762-4344 Dir: William F. Hancock, MD \n Professional component performed at LabCorp, Alamance Regional Medical Center, 1240 Huffman Mill Rd, Burlington, NC 27215 Lab: 336-538-7833 Dir: Tara C. Rubinas, MD \n .\n\n\n"
}